The AI industry is closing ranks. Hours after Anthropic filed its lawsuit against the Department of Defense on Monday, nearly 40 employees from OpenAI and Google - including Jeff Dean, Google's chief scientist and Gemini lead - filed an amicus brief supporting the challenge. The rare cross-company show of solidarity signals deep concern over the Trump administration's decision to label Anthropic a supply chain risk, a designation typically reserved for foreign adversaries.
Anthropic just got backup from an unlikely alliance. The AI safety company filed its lawsuit against the Department of Defense on Monday morning, challenging its designation as a supply chain risk. By evening, nearly 40 researchers from OpenAI and Google had submitted an amicus brief in federal court supporting their competitor's legal fight.
The move is extraordinary. Jeff Dean, Google's chief scientist who leads the company's Gemini AI efforts, put his name on the brief alongside engineers and researchers who compete directly with Anthropic's Claude chatbot. This isn't the typical Silicon Valley rivalry - it's a coordinated response to what the brief describes as the administration's "unprecedented" application of supply chain restrictions to a domestic AI company.
The Trump administration designated Anthropic as a supply chain risk in late February, effectively restricting government agencies and contractors from using the company's AI systems. That designation has historically been reserved for foreign companies like Huawei or ZTE that officials believe pose national security threats. Applying it to a San Francisco-based company backed by Google and founded by former OpenAI executives represents a dramatic shift in how the Pentagon approaches AI governance.
According to The Verge's initial reporting, Anthropic's lawsuit argues the designation was arbitrary and violated administrative procedures. But the amicus brief from OpenAI and Google employees goes further, laying out technical concerns about how such designations could affect AI development across the industry.
The brief details how supply chain restrictions could fragment AI research and create conflicting standards between commercial and government applications. If agencies can't access certain AI models, the employees argue, it creates parallel development tracks that could actually reduce safety oversight. They point out that Anthropic has been a leader in AI safety research, publishing extensively on techniques like constitutional AI and harmlessness training.
What makes this coalition particularly striking is the timing. OpenAI and Google are locked in fierce competition with Anthropic for enterprise contracts and consumer adoption. OpenAI's ChatGPT and Google's Gemini compete directly with Anthropic's Claude across multiple market segments. Yet here are their top researchers arguing that the Pentagon's move threatens the entire industry's relationship with government.
The amicus brief suggests the signatories see the Anthropic designation as a potential template. If the administration can label one domestic AI company a supply chain risk based on opaque criteria, it could theoretically do the same to others. That uncertainty makes long-term planning nearly impossible for companies trying to navigate both commercial markets and government contracts.
Jeff Dean's participation is especially significant. As Google's chief scientist and a foundational figure in modern machine learning, his technical credibility carries weight beyond typical corporate positioning. His involvement signals this isn't just about competitive dynamics - it's about how the AI industry interfaces with national security apparatus.
The brief also addresses the technology's dual-use nature. AI models can be used for both beneficial applications like scientific research and potentially concerning ones like autonomous weapons or surveillance. The employees argue that blanket restrictions on specific companies don't address these use-case distinctions and could push development away from more safety-conscious firms.
Anthropic has positioned itself as the AI safety-first alternative to more commercially aggressive competitors. The company's public benefit corporation structure and extensive safety research were meant to differentiate it in a crowded market. The irony of being designated a supply chain risk isn't lost on the amicus signatories, who note this in their technical analysis.
The Defense Department hasn't publicly detailed its reasoning for the Anthropic designation, citing classified intelligence assessments. That opacity is part of what the lawsuit challenges - the company argues it deserves to know the specific basis for restrictions that could effectively kill its government business.
For OpenAI and Google employees to wade into this fight, even in personal capacities, suggests they're worried about precedent. If the Pentagon can restrict Anthropic based on undisclosed concerns, what stops similar designations from hitting other companies? The brief makes clear these aren't just hypothetical worries - they're live concerns among researchers trying to build AI systems that work with government while maintaining safety standards.
This case could define how the Trump administration handles AI governance more broadly. Does it treat domestic companies as potential security threats? Does it favor certain firms over others in the emerging AI industrial policy? The answers will shape whether Silicon Valley and Washington can maintain a productive relationship as AI becomes increasingly central to both commercial and national security applications.
The cross-company amicus brief transforms Anthropic's lawsuit from a single company's legal challenge into an industry-wide statement about AI governance. With top researchers from competing firms warning that supply chain designations could fragment development and reduce safety oversight, the case now carries implications for every major AI company navigating the intersection of commercial innovation and national security. How the courts handle this unprecedented application of supply chain restrictions to a domestic AI firm will likely set the template for how Washington regulates the technology for years to come.
